Transforming growth factor β production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats

Virchows Archiv

Volumn 438, Issue 5, 2001, Pages 492-497

  Kuwahara, Maki ^a   Takeda, Makio ^a   Takeuchi, Yukiko ^a   Kuwahara, Masayoshi ^b   Harada, Takanori ^a   Maita, Keizo ^a  

^a INSTITUTE OF ENVIRONMENTAL TOXICOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Rat; Spontaneous malignant mesothelioma; Transforming growth factor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; MALIGNANT MESOTHELIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RAT STRAIN;

ANIMALS; CELL COUNT; CELL DIVISION; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PERITONEUM; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; RETROPERITONEAL NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0035034267     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000363     Document Type: Article

References (37)

1. 1. Assoian RK, Fleurdelys BE, Stevenson HC, Miller P, Madtes DK, Raines EW, Ross R, Sporn MB (1987) Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020-6024
2. 2. Barnard IA, Lyons RM, Moses HL (1990) The cell biology of transforming growth factor beta. Biochem Biophys Acta 1032:29-87
3. 3. Bermudez E, Everitt J, Walker C. (1990) Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp Cell Res 190:91-98
4. 4. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB (1989) Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 138:79-86
5. 5. Fitzpatrick DR, Peroni DJ, Bielefeldt-Ohmann H. (1995) The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am J Respir Cell Mol Biol 12:455-460
6. 6. Fitzpatrick DR, Bielefeldt-Ohmann H, Himbeck RP, Jarnicki AG, Marzo AL, Robinson BWS (1994) Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma. Growth Factors 11:29-44
7. 7. Gabrielson EW, Gerwin BI, Harris CC, Roberts AB, Sporn MB, Lechner JF (1988) Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors. FASEB J 2:2717-2721
8. 8. Garlepp MJ, Leong CC (1995) Biological and immunological aspects of malignant mesothelioma. Eur Respir J 8:643-650
9. 9. Gerwin BI, Lechner JF, Reddle RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC (1987) Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 47:6180-6184
10. 10. Gould DH (1977) Mesotheliomas in tunica vaginalis propria and peritoneum in Fischer rats. Vet Pathol 14:372-379
11. 11. Hall WC (1990) Peritoneum, retroperitoneum, mesentery, and abdominal cavity. In: Boorman GA, Eustis SL, Elwell MR, Montogomery CA Jr, Machenzie WF (eds) Pathology of the Fischer rat, part 6. Academic Press, San Diego
12. 12. Iwata H, Hirouchi Y, Koike Y, Yamakawa S, Kobayashi K, Yamamoto T, Kobayashi K, Inoue H, Enomoto M (1991) Historical control data of non-neoplastic and neoplastic lesions in F344/DuCrj rats. J Toxicol Pathol 4:1-24
13. 13. Jagirdar J, Lee TC, Reibman J, Gold LI, Aston C, Begin R, Rom WN (1997) Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect 105[Suppl 5]:1197-1203
14. 14. Japanese Association for Laboratory Animal Science, JALAS (1987) Guidelines for animal experimentation (in Japanese). Exp Anim 36:285-288
15. 15. Jarnicki AG, Fitzpatrick DR, Robinson BWS, Bielefeldt-Ohmann H (1996) Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma. Cancer Lett 103:1-9
16. 16. Kinnula VL, Linnala A, Viitala E, Linnainmaa K, Virtanen I (1998) Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. Am J Respir Cell Mol Biol 19:445-452
17. 17. Kumar-Singh S, Weyler J, Martin MJ, Vermeulen PB, van Marick F (1999) Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1, and -2, and TGF-β expression. J Pathol 189:72-78
18. 18. Kuwahara M, Inui K, Sugimoto K, Takeuchi Y, Takahashi K, Kuwahara M, Harada T, Maita K (1997) Establishment and characterization of spontaneous mesothelioma cell lines derived from F344 rats. Virchows Arch 431:257-263
19. 19. Langerak AW, van der Linden-van Beruden CAJ, Versnell MA (1996) Regulation of differential expression of platelet-derived growth factor α- and β-receptor mRNA in normal and malignant mesothelial cell lines. Biochem Biophys Acta 1305:63-75
20. 20. Lauber B, Leuthold M, Schmitter D, Cano-Santos J, Waibel R, Stahel RA (1992) An autocrine mitogenic activity produced by pleural human mesothelioma cell line. Int J Cancer 50:943-950
21. 21. Laveck MA, Somers ANA, Moore LL, Gerwin BI, Lechner JF (1988) Dissimilar peptide growth factors can induce normal human mesothelial cell multiplication. In Vitro Cell Dev Biol 24:1077-1084
22. 22. Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, Higashino K (1994) Transforming growth factor-beta 1 (TGF-β1)- and β2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 98:319-322
23. 23. Maekawa Y, Kurokawa Y, Takahashi M, Kokubo T, Ogiu T, Onodera H, Tajima H. Ohno Y, Furukawa F, Hayashi Y (1983) Spontaneous tumors in F-344/DuCrj rats. Gann 74:365-372
24. 24. Maita K, Hirano M, Harada T, Mitsumori K, Yoshida A, Takahashi K, Nakashima N, Kitazawa T, Enomoto A, Inui K, Shirasu (1987) Spontaneous tumors in F344/DuCrj rats from 12 control groups of chronic and oncogenicity studies. J Toxicol Sci 12:111-126
25. 25. Marzo AM, Fitzpatrick DR, Robinson WS, Scott B (1997) Antisense oligonucleotides specific for transforming growth factor β2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Cancer Res 57:3200-3207
26. 26. Mossman BT, Hansen K, Marsh JP, Breww ME, Hill S, Bergeron M, Petruska J (1989) Bignon J, Peto J, Saracci R (eds) Non-occupational exposure to mineral fibers. IARC scientific publications no. 90, International Agency of Research on Cancer, France pp 81-92
27. 27. Orengo AM, Spoletini L, Procopio A, Favoni RE, De Cupis A, Ardizzoni A, Castagneto B, Ribotta M, Betta PG, Ferrini S, Mutti L (1999) Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunopheno-typic analysis. Eur Respir J 13:527-534
28. 28. Rom WN, Travis WD, Brody AR (1991) Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 143:408-422
29. 29. Rutten AAJJL, Bermudez E, Stewart W, Everitte JI, Walker C (1995) Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II. Cancer Res 55:3634-3639
30. 30. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S (1995) Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol 268: 972-982
31. 31. Tanigawa H, Onodera H, Maekawa A (1987) Spontaneous mesotheliomas in Fischer rats - a histological and electron microscopic study. Toxicol Pathol 15:157-163
32. 32. Todaro GJ, Fryling C, De Larco JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A 77:5258-5262
33. 33. Tzanakakis GN, Hjerpe A, Karamanos NK (1997) Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79:323-332
34. 34. Tzanakakis GN, Karamanos NK, Hjerpe A (1995) Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp Cell Res 220:130-137
35. 35. Versnel MA, Hagemeijer A, Bouts MJ, Van der Kwast TH, Hoogsteden HC (1988) Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene 2:601-605
36. 36. Walker C, Bermudez E, Stewart W, Bonner J, Molloy CJ, Everitt J (1992) Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma. Cancer Res 52:301-306
37. 37. Walker C, Everitt J, Ferriola CF, Stewart W, Mangum J, Bermudez E (1995) Autocrine growth stimulation by transforming growth factor α in asbestos-transformed rat mesothelial cells. Cancer Res 55:530-536